These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31208696)

  • 1. Epigenome Remodeling in Cholangiocarcinoma.
    O'Rourke CJ; Lafuente-Barquero J; Andersen JB
    Trends Cancer; 2019 Jun; 5(6):335-350. PubMed ID: 31208696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome dysregulation in cholangiocarcinoma.
    O'Rourke CJ; Munoz-Garrido P; Aguayo EL; Andersen JB
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1423-1434. PubMed ID: 28645654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation in the carcinogenesis of cholangiocarcinoma.
    Chiang NJ; Shan YS; Hung WC; Chen LT
    Int J Biochem Cell Biol; 2015 Oct; 67():110-4. PubMed ID: 26100596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
    Banales JM; Cardinale V; Carpino G; Marzioni M; Andersen JB; Invernizzi P; Lind GE; Folseraas T; Forbes SJ; Fouassier L; Geier A; Calvisi DF; Mertens JC; Trauner M; Benedetti A; Maroni L; Vaquero J; Macias RI; Raggi C; Perugorria MJ; Gaudio E; Boberg KM; Marin JJ; Alvaro D
    Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):261-80. PubMed ID: 27095655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
    Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
    Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Epigenomic Factors in Bile Duct Cancer.
    Rogalska-Taranta M; Andersen JB
    Semin Liver Dis; 2022 May; 42(2):202-211. PubMed ID: 35738258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
    Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of epigenetic regulation in cholangiocarcinogenesis.
    Zhong B; Liao Q; Wang X; Wang X; Zhang J
    Biomed Pharmacother; 2023 Oct; 166():115290. PubMed ID: 37557012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
    Rimassa L; Personeni N; Aghemo A; Lleo A
    J Autoimmun; 2019 Jun; 100():17-26. PubMed ID: 30862450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE
    Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of cholangiocarcinoma carcinogenesis.
    Maemura K; Natsugoe S; Takao S
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):754-60. PubMed ID: 24895231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic alterations in cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio- carcinoma due to SOCS3 epigenetic silencing.
    Isomoto H
    Digestion; 2009; 79 Suppl 1():2-8. PubMed ID: 19153483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Cholangiocarcinoma.
    Rodrigues PM; Olaizola P; Paiva NA; Olaizola I; Agirre-Lizaso A; Landa A; Bujanda L; Perugorria MJ; Banales JM
    Annu Rev Pathol; 2021 Jan; 16():433-463. PubMed ID: 33264573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges to underpinning the genetic basis for cholangiocarcinoma.
    Cigliano A; Chen X; Calvisi DF
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):511-526. PubMed ID: 33888034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of epigenetic alterations in cholangiocarcinoma.
    Tischoff I; Wittekind C; Tannapfel A
    J Hepatobiliary Pancreat Surg; 2006; 13(4):274-9. PubMed ID: 16858537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
    Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
    Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs.
    Stutes M; Tran S; DeMorrow S
    World J Gastroenterol; 2007 Dec; 13(48):6465-9. PubMed ID: 18161915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH1 as a frequently mutated gene has potential effect on exosomes releasement by epigenetically regulating P2RX7 in intrahepatic cholangiocarcinoma.
    Zhang X; Miao R; Liu T; Xiang X; Gu J; Jia Y; Li Z; Fu Y; He Y; Zhang Y; Zhang J; Qu K; Liu C
    Biomed Pharmacother; 2019 May; 113():108774. PubMed ID: 30889491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.